Pipeline
Homing Therapeutics focuses on developing transformative cell therapies through navigating therapeutic immune cells. By integrating advanced gene editing and chemical induction technologies, our products can significantly enhance the accessibility of CAR T cells in cancer maintenance sites.
Products
HoM-01
​Target Cells
​
​
CAR T ​​​​​
​Engineer Strategy
Genetic ​​​​​
​Receptor
Receptor A ​​​​​
Delivering Tissues
Bone Marrow
​Disease Indications
ALL, NHL, MM
HoM-02
​Target Cells
​
CAR T ​​​​​
​Engineer Strategy
Chemical ​​​​​
​Receptor
Receptor B ​​​​​
Delivering Tissues
Bone Marrow
​Disease Indications
ALL, NHL, MM
Road Map
Discovery & IND-enabling Phase I/IIA Phase III Validation
HoM-01
HoM-02